Home › Funds › Center for Wealth Management Advisory › ABT

Center for Wealth Management Advisory position in ABT

ABBOTT LABORATORIES · Health Care

Center for Wealth Management Advisory reported holding 18,246 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 1.12% of its reported portfolio and ranking #30 among its reported holdings. Center for Wealth Management Advisory has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)18.25K sh
Reported value held$1.80M
Portfolio Weight1.12%
First reportedQ4 2025
Last changeAdd
Updated2026-10-23

Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR

How Center for Wealth Management Advisory's ABT position evolved

Center for Wealth Management Advisory first disclosed a stake in ABT in Q4 2025 at 15,730 shares (US$2.0M). Across 4 filings, Center for Wealth Management Advisory increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 18,246 shares valued at US$1.8M — an increase of 1,013 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 15.73K $1.97M New
Q1 2026 16.45K $1.69M Add
Q2 2026 17.23K $1.56M Add
Q3 2026 18.25K $1.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Center for Wealth Management Advisory held ABT?

Center for Wealth Management Advisory has disclosed ABT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Center for Wealth Management Advisory's current position in ABT?

As of Q3 2026, Center for Wealth Management Advisory holds 18.25K shares of ABT (ABBOTT LABORATORIES), valued at $1.80M, representing 1.12% of its reported portfolio and ranking #30.

Has Center for Wealth Management Advisory been buying or selling ABT?

In the latest 13F filing (Q3 2026), Center for Wealth Management Advisory increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.